Iverpantin 12mg Tablet DT contains Ivermectin 12mg, a broad-spectrum antiparasitic agent effective against a variety of parasitic infections. Ivermectin acts by binding selectively and with high affinity to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, leading to increased permeability to chloride ions, hyperpolarization, paralysis, and death of the parasite. This formulation is designed as a dispersible tablet, facilitating ease of administration, particularly in patients with swallowing difficulties. Iverpantin is indicated for the treatment of onchocerciasis (river blindness), strongyloidiasis, and other parasitic infestations such as scabies and lice. The drug demonstrates a favorable safety profile when used as prescribed, with common adverse effects including mild gastrointestinal discomfort, dizziness, and transient skin reactions. It is contraindicated in patients with known hypersensitivity to ivermectin or any tablet excipients. Caution is advised in patients with impaired liver function or concurrent use of other neurotoxic drugs. Dosage and duration of therapy should be determined based on the specific parasitic infection and patient weight. Iverpantin 12mg Tablet DT should be used under medical supervision to ensure optimal efficacy and minimize the risk of resistance development.